Does Reishi Immune Randomized Trial work?

Updated May 2026

Quick Answer

Reishi Immune Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: Recognized as pathogen-associated molecular patterns (PAMPs) in the intestine, β-glucans and proteoglycans boost innate immunity and enhance the adaptive immune response to different antigens.

Key Takeaways

  • 01Recognized as pathogen-associated molecular patterns (PAMPs) in the intestine, β-glucans and proteoglycans boost innate immunity and enhance the adaptive immune response to different antigens. [Kirdeeva Yulia (2026)]
  • 02Finally, we will discuss the safety, limitations, and clinical experience associated with the use of medical mushrooms in oncology. [Kirdeeva Yulia (2026)]
  • 03Agaricus bisporus Lentinula edodes Pleurotus ostreatus Pleurotus eryngii Auricularia heimuer Volvariella volvacea Flammulina filiformis Figure 1 First, consumption has increased due to the commercial cultivation of mushrooms. [Kirdeeva Yulia (2026)]
  • 041 2 3 4 5 6 7 8 Agaricus bisporus Pleurotus ostreatus Volvariella volvacea Natural compounds from plants and mushrooms are a source of continuous development for anticancer therapeutics [,,,,]. [Kirdeeva Yulia (2026)]
The current Migaku evidence database contains 2 reusable source documents for Reishi Immune Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove. - Recognized as pathogen-associated molecular patterns (PAMPs) in the intestine, β-glucans and proteoglycans boost innate immunity and enhance the adaptive immune response to different antigens. [Kirdeeva Yulia (2026); evidence level 3] - Finally, we will discuss the safety, limitations, and clinical experience associated with the use of medical mushrooms in oncology. [Kirdeeva Yulia (2026); evidence level 3] - Agaricus bisporus Lentinula edodes Pleurotus ostreatus Pleurotus eryngii Auricularia heimuer Volvariella volvacea Flammulina filiformis Figure 1 First, consumption has increased due to the commercial cultivation of mushrooms. [Kirdeeva Yulia (2026); evidence level 3] - 1 2 3 4 5 6 7 8 Agaricus bisporus Pleurotus ostreatus Volvariella volvacea Natural compounds from plants and mushrooms are a source of continuous development for anticancer therapeutics [,,,,]. [Kirdeeva Yulia (2026); evidence level 3] - Purpose of review Biochemical recurrence of epithelial ovarian cancer (EOC), defined as rising CA-125 levels without clinical or radiologic evidence of disease, is a frequent and challenging scenario. [Berman T (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. The Inclusion of Dietary and Medicinal Mushrooms into Translational Oncology: Pros and Cons at the Molecular Level
  2. Integrative Oncology for Biochemical Recurrence of Epithelial Ovarian Cancer.